STAT+: Judge skeptical of arguments against Medicare drug price negotiation
STAT
JANUARY 31, 2024
It didn’t go well for them. “You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process.
Let's personalize your content